Table 5 Medians for each disease group: recommendations rated “disagree” overalla
Question | Overall median | Mean absolute deviation from the median (MADM) | Median amongst mental health panellists N = 5 | Median amongst cancer panellists N = 6 | Median amongst heart failure panellists N = 5 | |
|---|---|---|---|---|---|---|
56 | MDT meetings should be a forum for brainstorming and giving advice without necessarily reaching a decision | 3 | 1.25 | 3 | 3 | 2 |
57 | Only complex cases should be discussed in the MDT meetings (regardless of whether they are new or existing patients) | 3 | 1.31 | 3 | 2 | 3 |
58 | It is more important to discuss all patients, even if superficially, than it is to discuss a smaller number of patients in more depth | 3.5 | 1.69 | 2 | 5 | 2 |
59 | There should be time within MDT meetings to discuss current and emerging research and evidence which is not specifically related to an individual case | 3.5 | 2.38 | 6 | 3.5 | 3 |
60 | Members should be allowed to join the meeting for cases that are relevant to them and leave after the discussion of these | 3 | 1.19 | 3 | 3 | 3 |
61 | Patients’ treatment preferences should be routinely discussed at the MDT meeting and if not available the case should not be discussed | 3 | 1.94 | 5 | 4 | 2 |
62 | Patient preferences regarding available management options should be reported to the MDT meeting only if the clinician responsible for their care thinks it will alter the decision | 3 | 2.00 | 5 | 3.5 | 2 |
63 | Patients should be asked before the MDT how much they want to be involved in decision-making about their treatment | 3 | 1.88 | 3 | 2.5 | 3 |
64 | All patients should be told if they are going to be discussed at an MDT meeting before the meeting otherwise they should not be discussed | 2 | 1.88 | 5 | 1 | 2 |
65 | All patients should be explicitly given the choice of whether or not to be discussed at the MDT meeting | 1.5 | 1.19 | 2 | 1 | 1 |
66 | Patients should not be given an explicit choice, but if they express concern about being discussed at the MDT meeting they should be allowed to opt out | 2 | 1.25 | 2 | 2 | 5 |
67 | Patients should be given the option of attending MDT meetings | 1 | 1.19 | 5 | 1 | 1 |
68 | Patients should be given MDT meeting feedback only when decisions are made about their care | 3 | 1.06 | 3 | 3 | 5 |